London12% of myeloma patients have cancer already traveling.
It flags the worst-risk patients current staging alone would miss entirely.
A marrow needle samples one spot in a disease spread through the whole skeleton, but blood catches traveling cells.
Researchers must validate the 0.38% threshold before it enters routine staging.
Sources: Nature